Wednesday, October 14, 2026

HealthTap, a virtual primary care provider, announced Monday the launch of a new program designed to support sleep and respiratory durable medical equipment (DME) suppliers.

The Sunnyvale, California-based company delivers primary care across all 50 states through partnerships with payers, pharmacies, providers, and cost-sharing organizations. Its latest offering connects patients with sleep disorders to physicians for clinical evaluations, documentation, and orders—services often required before insurers or suppliers can initiate therapy or provide equipment. The program supports positive airway pressure (PAP) therapy from initial evaluation and treatment orders through compliance monitoring, resupply, and device replacement.

Following each physician visit, chart notes and orders are transmitted directly to the supplier. HealthTap also provides real-time updates when patients book, complete, cancel, miss, or reschedule appointments.

“Physicians review relevant records and device data, evaluate the patient, and return completed notes and clinically appropriate orders through integrated workflows,” said Sean Mehra, HealthTap CEO. “Suppliers get real-time visit and documentation updates instead of chasing paperwork.”

Mehra noted that DME suppliers often work diligently to keep patients on therapy, but accessing physicians for necessary documentation can be challenging.

“Delays in appointments, prescriptions, or required documentation can hold up orders, disrupt patient care, and delay reimbursement,” he said. “We launched this program to help DME suppliers overcome these challenges by giving them fast, reliable access to physicians, integrated clinical workflows, and timely documentation—so they can reduce administrative burden, keep patients on therapy, and keep their operations moving.”

Approximately 30 million adults in the U.S. have obstructive sleep apnea. For those using PAP therapy, physician involvement is critical. Under Medicare, continued coverage for certain PAP devices requires a treating practitioner to reevaluate the patient between days 31 and 91 after therapy begins and document clinical benefit and patient adherence.

Ultimately, HealthTap aims to help patients easily initiate and maintain therapy, Mehra said.

“Someone needing a follow-up evaluation or an updated prescription should have an easy way to see a physician and understand the next steps,” he said. “For DME suppliers, the goal is to remove uncertainty from helping that patient. Their teams spend significant time calling physician offices, checking if a visit occurred, and waiting for documentation before they can move forward. Through integrated workflows, completed visit notes and medically appropriate signed orders reach suppliers immediately after the visit. This gives their teams a clearer path forward and helps patients avoid further waiting.”

Photo: elenabs, Getty Images

Source link

Exit mobile version